Filed: 8/14/2025ACC: 0001172661-25-003478
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $153.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$153.80M
Total AUM (reported)
26.64M
Total Shares
Allocation by class
COM$82.88M53.9%
SPONSORED ADS$28.69M18.7%
COM NEW$28.54M18.6%
COMMON STOCK$6.58M4.3%
COM SHS$3.46M2.3%
CLASS A ORD SHS$3.33M2.2%
CL A ORD SHS$312.0K0.2%
Portfolio Concentration
Top 3$46.10M30.0%
4–10$56.27M36.6%
11–25$51.11M33.2%
Rest$312.0K0.2%
Top 3 weight
30.0%
Top 10 weight
66.6%
Voting Authority Distribution
Total shares with voting rights: 26.64M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
26.64M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings26
Rows:
IONIS PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$19.75M
12.84%
Sole
0.00
Shared
500K
None
0.00
REZOLUTE INC
SOLEShares3.03M
TypeSH
Market value$13.53M
8.80%
Sole
0.00
Shared
3.03M
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares2M
TypeSH
Market value$12.82M
8.34%
Sole
0.00
Shared
2M
None
0.00
LEGEND BIOTECH CORP
SOLEShares350K
TypeSH
Market value$12.42M
8.08%
Sole
0.00
Shared
350K
None
0.00
ABIVAX SA
SOLEShares1.29M
TypeSH
Market value$9.88M
6.42%
Sole
0.00
Shared
1.29M
None
0.00
NEUROGENE INC
SOLEShares485.86K
TypeSH
Market value$7.26M
4.72%
Sole
0.00
Shared
485.86K
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares1.99M
TypeSH
Market value$7.23M
4.70%
Sole
0.00
Shared
1.99M
None
0.00
EVOLUS INC
SOLEShares720.12K
TypeSH
Market value$6.63M
4.31%
Sole
0.00
Shared
720.12K
None
0.00
ARCELLX INC
SOLEShares100K
TypeSH
Market value$6.58M
4.28%
Sole
0.00
Shared
100K
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares200K
TypeSH
Market value$6.26M
4.07%
Sole
0.00
Shared
200K
None
0.00
AKERO THERAPEUTICS INC
SOLEShares103.85K
TypeSH
Market value$5.54M
3.60%
Sole
0.00
Shared
103.85K
None
0.00
JADE BIOSCIENCES INC
SOLEShares498.05K
TypeSH
Market value$4.98M
3.24%
Sole
0.00
Shared
498.05K
None
0.00
CYTOKINETICS INC
SOLEShares150K
TypeSH
Market value$4.96M
3.22%
Sole
0.00
Shared
150K
None
0.00
IMMUNOVANT INC
SOLEShares262.18K
TypeSH
Market value$4.19M
2.73%
Sole
0.00
Shared
262.18K
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares796.56K
TypeSH
Market value$3.80M
2.47%
Sole
0.00
Shared
796.56K
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares323.17K
TypeSH
Market value$3.65M
2.38%
Sole
0.00
Shared
323.17K
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares1.50M
TypeSH
Market value$3.46M
2.25%
Sole
0.00
Shared
1.50M
None
0.00
DBV TECHNOLOGIES S A
SOLEShares374.68K
TypeSH
Market value$3.43M
2.23%
Sole
0.00
Shared
374.68K
None
0.00
ZURA BIO LTD
SOLEShares3.17M
TypeSH
Market value$3.33M
2.16%
Sole
0.00
Shared
3.17M
None
0.00
UPSTREAM BIO INC
SOLEShares300K
TypeSH
Market value$3.29M
2.14%
Sole
0.00
Shared
300K
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares4.68M
TypeSH
Market value$3.07M
2.00%
Sole
0.00
Shared
4.68M
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares225K
TypeSH
Market value$2.96M
1.92%
Sole
0.00
Shared
225K
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares61.61K
TypeSH
Market value$2.18M
1.42%
Sole
0.00
Shared
61.61K
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares2.65M
TypeSH
Market value$1.28M
0.83%
Sole
0.00
Shared
2.65M
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares850K
TypeSH
Market value$986.0K
0.64%
Sole
0.00
Shared
850K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INCSOLE | COM | 500K | SH | $19.75M 12.84% | 0.00 | 500K | 0.00 |
REZOLUTE INCSOLE | COM NEW | 3.03M | SH | $13.53M 8.80% | 0.00 | 3.03M | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 2M | SH | $12.82M 8.34% | 0.00 | 2M | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 350K | SH | $12.42M 8.08% | 0.00 | 350K | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.29M | SH | $9.88M 6.42% | 0.00 | 1.29M | 0.00 |
NEUROGENE INCSOLE | COM | 485.86K | SH | $7.26M 4.72% | 0.00 | 485.86K | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 1.99M | SH | $7.23M 4.70% | 0.00 | 1.99M | 0.00 |
EVOLUS INCSOLE | COM | 720.12K | SH | $6.63M 4.31% | 0.00 | 720.12K | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 100K | SH | $6.58M 4.28% | 0.00 | 100K | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 200K | SH | $6.26M 4.07% | 0.00 | 200K | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 103.85K | SH | $5.54M 3.60% | 0.00 | 103.85K | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 498.05K | SH | $4.98M 3.24% | 0.00 | 498.05K | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 150K | SH | $4.96M 3.22% | 0.00 | 150K | 0.00 |
IMMUNOVANT INCSOLE | COM | 262.18K | SH | $4.19M 2.73% | 0.00 | 262.18K | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM NEW | 796.56K | SH | $3.80M 2.47% | 0.00 | 796.56K | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 323.17K | SH | $3.65M 2.38% | 0.00 | 323.17K | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 1.50M | SH | $3.46M 2.25% | 0.00 | 1.50M | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 374.68K | SH | $3.43M 2.23% | 0.00 | 374.68K | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 3.17M | SH | $3.33M 2.16% | 0.00 | 3.17M | 0.00 |
UPSTREAM BIO INCSOLE | COM | 300K | SH | $3.29M 2.14% | 0.00 | 300K | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 4.68M | SH | $3.07M 2.00% | 0.00 | 4.68M | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 225K | SH | $2.96M 1.92% | 0.00 | 225K | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 61.61K | SH | $2.18M 1.42% | 0.00 | 61.61K | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM NEW | 2.65M | SH | $1.28M 0.83% | 0.00 | 2.65M | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 850K | SH | $986.0K 0.64% | 0.00 | 850K | 0.00 |
Page 1 of 2